Comparison of Sacral Erector Spinae Plane Block and Supra-Inguinal Fascia Iliaca Block for Analgesia After Hip Fracture Surgery

NCT07081867 | Completed

• 1 other identifier: CT-ERHO-AR-BA-01
• Study Type: observational
• Target: 77
• Locations: 1 country
• Sites: 1

Brief Summary

This study compares the postoperative analgesic effectiveness of Sacral Erector Spinae Plane Block (SESPB) and Supra-Inguinal Fascia Iliaca Block (SIFIB) in patients undergoing hip fracture surgery. Both techniques are regional anesthesia methods aiming to reduce postoperative pain and opioid consumption. The study evaluates pain scores, opioid requirements, mobilization times, and hospital discharge times to determine which block provides more effective pain management in different postoperative periods.

Conditions

Postoperative Pain Management; Regional Anesthesia; Elderly Patients; Hip Fracture Surgery

Keywords

Nerve Block; Anesthesia, Regional; Hip Fractures; Postoperative Pain; Analgesia; Visual Analog Scale; Pain Measurement

Outcome Measures

Primary Outcomes (4)

• Postoperative Pain Scores

  Pain intensity measured using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Pain scores will be recorded at specific postoperative time points: 1st, 6th, 12th, and 24th hours.

  At 1 hour, 6 hours, 12 hours, and 24 hours postoperatively.

• Time to First Postoperative Analgesic Requirement

  Time interval from end of surgery to the first request for analgesia.

  Up to 48 hours postoperatively.

• Total Postoperative Opioid Consumption

  The total amount of opioids required by patients during the postoperative period.

  A week

• Time to First Mobilization

  The time until patients' first mobilization (walking or standing) after surgery.

  From the end of surgery until first mobilization, typically within 24 to 48 hours postoperatively

Secondary Outcomes (2)

• Length of Hospital Stay

  Up to 14 days postoperatively.

• Block-Related Complications

  A week

Study Arms (2)

SIFIB Group

Patients who underwent Supra-Inguinal Fascia Iliaca Block (n=40)

Procedure: Supra-inguinal Fascia Iliaca Block (SIFIB)

SESPB Group

Patients who underwent Sacral Erector Spinae Plane Block (n=37)

Procedure: Sacral Erector Spinae Plane Block (SESPB)

Interventions

Supra-inguinal Fascia Iliaca Block (SIFIB) PROCEDURE

Ultrasound-guided injection of 40 mL of 0.25% bupivacaine between the iliacus muscle and fascia iliaca via a supra-inguinal approach, performed preoperatively for postoperative analgesia in patients undergoing hip fracture surgery under spinal anesthesia.

SIFIB Group

Sacral Erector Spinae Plane Block (SESPB) PROCEDURE

Ultrasound-guided injection of 40 mL of 0.25% bupivacaine into the fascial plane deep to the erector spinae muscle at the sacral level (S2), performed preoperatively for postoperative analgesia in patients undergoing hip fracture surgery under spinal anesthesia.

SESPB Group

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 65 years and older who underwent hip fracture surgery under spinal anesthesia at Prof. Dr. Cemil Taşçıoğlu City Hospital between January and June 2025. Only patients who provided written informed consent and met the inclusion criteria were enrolled.

You may qualify if:

• Patients aged 65 years and older
• Patients undergoing surgery for hip fractures under spinal anesthesia
• Patients who are oriented and cooperative
• Patients who have signed an informed consent form

You may not qualify if:

• Patients with contraindications for spinal anesthesia
• Patients with Alzheimer's disease or dementia, and those who are non-oriented or non-cooperative
• Patients with major organ failure (such as heart, liver, or kidney failure)
• Patients who decline to participate in the study
• Patients classified as American Society of Anesthesiologists (ASA) Physical Status IV or higher
• Patients with pathological fractures or bone metastasis

Sponsors & Collaborators

• Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization: lead

Study Sites (1)

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Istanbul, Sisli, 34384, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hip Fractures; Pain, Postoperative; Agnosia

Condition Hierarchy (Ancestors)

Femoral Fractures; Fractures, Bone; Wounds and Injuries; Hip Injuries; Leg Injuries; Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms; Perceptual Disorders; Neurobehavioral Manifestations; Nervous System Diseases

Study Officials

• Beyzanur Aydogdu

  Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident Doctor

Study Record Dates

• First Submitted: July 9, 2025
• First Posted: July 23, 2025
• Study Start: January 15, 2025
• Primary Completion: June 15, 2025
• Study Completion: December 1, 2025
• Last Updated: January 23, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)